Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Janssen describes vasoconstrictors for migraine Rx

Oct. 4, 1996

Potential of cannabinoid derivative in pain and inflammation

Oct. 4, 1996

Tachykinin antagonists disclosed by Sanofi

Oct. 4, 1996

Glaxo Wellcome prepares a novel class of glycine-site NMDA receptor antagonists

Sep. 27, 1996

Yamanouchi describes AMPA antagonists for stroke

Sep. 27, 1996

Sagami prepares NGF production-enhancing compounds

Sep. 27, 1996

Natural cerebral function-improving agents from Yamanouchi

Sep. 27, 1996

Neurite outgrowth inducers presented by Kitasato Institute

Sep. 27, 1996

Rilutek now available for ALS patients in the U.K.

Sep. 27, 1996

Novel antiemetic/gastric prokinetic agent from Dainippon

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...